From Target Biology to Lead Optimization
Drug discovery requires seamless collaboration between discovery biologists and medicinal chemists to translate biological insights into successful therapeutic candidates. CAS BioFinder® enables researchers to connect disease biology, targets, pathways, bioactivity data, chemical intelligence, and pharmacological evidence within a single integrated platform.
Join us for an exclusive webinar to discover how CAS BioFinder supports end-to-end drug discovery workflows, from disease landscape assessment and target validation to hit identification, SAR analysis, and lead optimization. Through practical demonstrations and real-world examples, we will showcase how scientists can leverage curated biological and chemical data, predictive analytics, and AI-assisted insights to make more informed research decisions and accelerate innovation.
Complete the form to secure your access. A confirmation will be sent to your inbox.
Eight practical capabilities, demonstrated live with real-world examples.
Identify promising therapeutic targets using integrated biological insights.
Explore biomarkers, pathways, and disease mechanisms.
Evaluate targets with ADME, metabolism, and toxicity data.
Discover relevant compounds from literature and patents.
Leverage SAR insights to optimize lead compounds.
Apply MMPA and molecular transformation strategies.
Connect biology and chemistry for better research decisions.
Use AI-driven insights to identify high-potential drug candidates faster.
Hear directly from the CAS customer success team working with drug discovery researchers every day.
Tuesday, 27 October 2026, 3:30 PM IST, live online. Seats are confirmed by email.